This medicinal product is for diagnostic use only. OPTISON is a transpulmonary echocardiographic contrast agent for use in patients with suspected or established cardiovascular disease to provide opacification of cardiac chambers, enhance left ventricular endocardial border delineation with resulting improvement in wall motion visualisation. OPTISON should only be used in patients where the study without contrast enhancement is inconclusive.
This medicinal product is for diagnostic use only. Luminity is an ultrasound contrast-enhancing agent for use in adult patients in whom non-contrast echocardiography was suboptimal (suboptimal is considered to indicate that at least two of six segments in the 4- or 2-chamber view of the ventricular border were not evaluable) and who have suspected or established coronary artery disease, to provide opacification of cardiac chambers and improvement of left ventricular endocardial border delineation at both rest and stress.
A multi-centre study performed to date using radioembolisation report a significantly prolonged survival benefit following SIR-Spheres microspheres in patients with...
Boston Scientific has entered into a definitive agreement to acquire the interventional radiology portfolio of CeloNova Biosciences, a San Antonio-based...
A major head-to-head study has shown that SIR-Spheres Y-90 resin microspheres, from Sirtex, administered once directly to the liver offers...
An analysis of a study of SIR-Spheres microspheres, from Sirtex, in the treatment of patients with inoperable primary Liver Cancer,...
SIRFLOX and FOXFIRE Global findings with SIR-Spheres Microspheres from Sirtex suggest that adding liver-directed Selective Internal Radiation Therapy (SIRT) to...